BillionToOne vs DEARhealth

<p>BillionToOne offers cutting-edge healthcare software leveraging proprietary Quantitative Counting Templates (QCTs™) technology to enable highly precise DNA analysis. It provides non-invasive prenatal testing (NIPT) and liquid biopsy solutions that help you assess fetal risk for genetic conditions and monitor cancer treatment response using just one blood draw. This makes prenatal and oncology diagnostics more accessible and accurate for healthcare providers and patients.</p> <p>With BillionToOne, you gain powerful tools for prenatal risk assessment and real-time oncology therapy monitoring. Its UNITY Complete® product provides early fetal risk screening, while the Northstar platform supports pan-cancer testing for therapy selection and response tracking. The software caters to healthcare professionals aiming for improved patient outcomes through advanced molecular diagnostics.</p>

<p>DEARhealth is a software as a medical device designed to support healthcare providers by offering dynamic and risk-based care pathways along with smart recommendations. It enables continuous remote monitoring of patients' health status, empowering you to deliver high quality care while managing patient load efficiently. The platform is clinically validated and complies with strict medical device regulations, making it a trusted tool for hospitals and healthcare providers worldwide.</p> <p>With DEARhealth, you gain capacity to treat more patients without compromising care quality by standardizing clinical workflows and optimizing healthcare consumption. Its proven benefits include fewer hospital visits, cost reduction, and improved patient empowerment. Whether you're a hospital, pharmaceutical company, or health plan, DEARhealth supports your clinical decision making and helps transition your operations towards hybrid healthcare delivery.</p>